Yakira Capital Management, Inc.
Position in APGE — Apogee Therapeutics, Inc.
CIK 1584639
Westport, CT
Position in APGE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$796,380
New position
Shares Held
6,000
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#189
of 284 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Yakira Capital Management, Inc. holds $3,480,869 across 8 Biotechnology names. APGE ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
133,047 | $1,789,482 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
This page
|
6,000 | $796,380 | |
| 3 | LSTA |
Lisata Therapeutics, Inc.
|
138,561 | $471,107 | |
| 4 | TECH |
BIO-TECHNE Corp
|
6,000 | $423,900 | |
| 5 | ESLA |
Estrella Immunopharma, Inc.
|
46,285 | $0 | |
| 6 | XOMA |
XOMA Royalty Corp
|
10,311 | $0 | |
| 7 | TVGN |
Tevogen Inc.
|
65,128 | $0 | |
| 8 | VRXA |
Veraxa Biotech Holding AG
|
98,360 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $796,380 | 6,000 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||